Zhen Su, Chief Executive Officer and Member Board of Directors at Marengo Therapeutics, Past Chair, Biotech Committee at Society for Immunotherapy of Cancer (SITC), shared a post on LinkedIn.
“Just returned from the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting feeling excited and energized about the future of clinical cancer research.
Beyond the remarkable scientific advances presented, what stood out most was the talent, passion, and commitment of the scientists and clinicians leading the field. We have an extraordinary community ready to accelerate the next wave of innovation and bring new hope to patients worldwide.
Grateful for the opportunity to learn, connect, and collaborate with so many inspiring colleagues.”
Other articles featuring Zhen Su on OncoDaily.
